Nuveen Asset Management, LLC Portfolio Holdings

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Nuveen Asset Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $345 Billion distributed in 9027 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $22B, Nvidia Corp with a value of $19.9B, Apple Inc. with a value of $19.2B, Amazon Com Inc with a value of $12.1B, and Meta Platforms, Inc. with a value of $9.2B.

Examining the 13F form we can see an increase of $11.1B in the current position value, from $334B to 345B.

Nuveen Asset Management, LLC is based out at Chicago, IL

Below you can find more details about Nuveen Asset Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $345 Billion
Technology: $107 Billion
Financial Services: $42.5 Billion
Healthcare: $38.6 Billion
Consumer Cyclical: $37.1 Billion
Industrials: $29.6 Billion
Communication Services: $27.9 Billion
Consumer Defensive: $17.1 Billion
Real Estate: $13.8 Billion
Other: $31.1 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.76B
$12.1 Million 0.0% of portfolio
91,070
Q3 2024 Reduced 1.02%
$3.56B
$4.14 Million 0.0% of portfolio
322,343
Q2 2024 Added 4.21%
$3.72B
$5.31 Million 0.0% of portfolio
260,200
Q3 2024 Added 2.52%
$15.3B
$14.7 Million 0.0% of portfolio
369,482
Q3 2024 Added 25.66%
$1.41B
$3.56 Million 0.0% of portfolio
116,453
Q2 2024 Reduced 37.24%
$4.25B
$9.89 Million 0.0% of portfolio
109,190
Q3 2024 Reduced 20.57%
$742M
$131,000 0.0% of portfolio
33,500
Q2 2024 New
Ge Healthcare Technologies I
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 22.12%
$138M
$2.2 Million 0.0% of portfolio
1,106,696
Q3 2024 Reduced 6.23%
$1.54B
$1.16 Million 0.0% of portfolio
352,239
Q3 2024 Reduced 21.68%
Hewlett Packard Enterprise C
-
$0 0.0% of portfolio
-
Q3 2024 New
$1.68B
$418,000 0.0% of portfolio
30,146
Q2 2024 Added 27.97%
$3.41B
$6.87 Million 0.0% of portfolio
205,091
Q3 2024 Added 5.14%
$2.35B
$10.6 Million 0.0% of portfolio
382,479
Q3 2024 Reduced 21.54%
$2.05B
$4.79 Million 0.0% of portfolio
149,338
Q2 2024 Reduced 36.37%
$4.91B
$7.67 Million 0.0% of portfolio
211,015
Q3 2024 Added 0.59%
$750M
$8.56 Million 0.0% of portfolio
1,049,123
Q3 2024 Added 0.1%
$693M
$3.5 Million 0.0% of portfolio
319,641
Q3 2024 Added 37.8%
$597M
$233,000 0.0% of portfolio
29,050
Q2 2022 New
$285M
$5.01 Million 0.0% of portfolio
516,739
Q3 2024 Added 423.18%
$2.17B
$5.27 Million 0.0% of portfolio
335,004
Q3 2024 Added 0.74%
$212M
$1.17 Million 0.0% of portfolio
455,313
Q3 2024 Reduced 56.89%
Revance Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 44.54%
$1.5B
$2.48 Million 0.0% of portfolio
100,216
Q1 2024 Reduced 6.97%
$763M
$10.2 Million 0.0% of portfolio
219,465
Q3 2024 Reduced 12.29%
$5.8B
$2.34 Million 0.0% of portfolio
75,284
Q3 2024 Added 15.71%
$3.46B
$7.75 Million 0.0% of portfolio
147,875
Q3 2024 Reduced 0.83%
$630M
$1.13 Million 0.0% of portfolio
348,828
Q3 2024 Reduced 0.83%
$169M
$264,000 0.0% of portfolio
21,406
Q4 2023 Added 38.43%
Rigel Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
$263M
$150,000 0.0% of portfolio
192,739
Q3 2024 Reduced 74.58%
$696M
$841,000 0.0% of portfolio
31,761
Q3 2024 Reduced 37.27%
$196M
$251,000 0.0% of portfolio
135,971
Q4 2023 Added 0.97%
$3.25B
$6.71 Million 0.0% of portfolio
212,246
Q3 2024 Reduced 1.27%
$197M
$763,000 0.0% of portfolio
477,412
Q3 2024 Reduced 37.32%
$2.07B
$5.63 Million 0.0% of portfolio
758,709
Q3 2024 Added 1.55%
$12B
$14.9 Million 0.0% of portfolio
1,536,038
Q3 2024 Added 82.25%
$1.07B
$3.1 Million 0.0% of portfolio
167,716
Q2 2024 Added 4.8%
$160M
$555,000 0.0% of portfolio
17,431
Q3 2024 Reduced 29.4%
$14B
$14.4 Million 0.0% of portfolio
357,682
Q3 2024 Reduced 0.44%
$1.94B
$8.23 Million 0.0% of portfolio
72,817
Q3 2024 Reduced 3.75%
$837M
$2.91 Million 0.0% of portfolio
130,261
Q3 2024 Reduced 7.71%
$6.97B
$14.5 Million 0.0% of portfolio
144,190
Q3 2024 Added 0.36%
$569M
$6.9 Million 0.0% of portfolio
644,286
Q3 2024 Added 37.24%
Pacs Group Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 168.62%
$396M
$459,000 0.0% of portfolio
270,184
Q2 2024 Reduced 60.26%
$763M
$4.49 Million 0.0% of portfolio
298,163
Q3 2024 Reduced 58.08%
$2.4B
$1.29 Million 0.0% of portfolio
112,473
Q3 2024 Added 3.9%
$1.87B
$11.5 Million 0.0% of portfolio
617,474
Q3 2024 Added 0.16%

Summary

  • Portfolio
  • No. of Stocks 9,027
  • Current Value $345 Billion
  • Prior Value $334 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 86 stocks
  • Additional Purchases 1,106 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1,417 stocks
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email